The Patent Poison Case: Securing Clinical Integrity
Case Summary
48 hours before NovaGene's public offering, a series of "patient testimonial" videos appeared on social media, showing alleged victims of a "systemic organ failure" caused by their lead therapy.
Narrative Mechanics
The videos utilized Deepfake Audio overlays on real footage of unrelated medical emergencies. The campaign was boosted by 400 "Medical Professional" personas created via Social Engineering prompts.
Counter-Tactics
Using Deepfake Attribution, SOVRINT identified the specific AI model used to generate the audio clones. We mapped the "Patient Advocates" to a single click-farm in Eastern Europe.
Final Assessment
NovaGene successfully executed their IPO with full regulatory backing after presenting SOVRINT's attribution report to the SEC.
Solutions Deployed.
The following SOVRINT solutions were utilized in this mission theater:
Start A Secure
Evaluation.
Built for agencies, governments, and regulated teams that need clear onboarding, evidence integrity, and deployment options from cloud to sovereign environments.
Security documentation, deployment diagrams, and governance materials are available during evaluation for qualified institutional teams.
How Engagement Works
Security And Mission Scoping
Align mission goals, data boundaries, and procurement constraints.
Evaluation Environment
Provision a controlled evaluation aligned to your deployment model.
Deployment Decision
Finalize architecture, support model, and onboarding timeline.